Riom, France
2025/04/29
Alphanosos is proud to announce a new scientific discovery partnership with Professor Stéphane Bézieau‘s team at l’institut du thorax (Nantes University, Inserm UMR1087, CNRS UMR 6291, Nantes University Hospital), France .
This collaboration will combine Alphanosos’ proprietary, AI-driven discovery platform with the academic expertise of Professor Bézieau’s group. The objective is to identify botanical extract combinations derived from edible plants that may help rescuing cellular dysfunction observed in models of neurodevelopmental disorders linked to the ubiquitin-proteasome system.
The long-term goal of this research is to explore the potential for safe, food-based supplementation approaches that could contribute to the management or modulation of certain neurodevelopmental conditions.
Created in 2004, l’institut du thorax is the result of the desire of doctors and researchers to establish a major training, research and care center around cardiac, vascular, metabolic and respiratory diseases.
Certified by Nantes Université, Inserm, CNRS and the Nantes University Hospital, l’institut du thorax carries out its public health mission with an ambition for excellence.
From improving fundamental knowledge to developing new treatments and implementing preventive measures, the medical and scientific teams at l’institut du thorax are sharing a single objective: Accelerate research for the benefit of the patient.
COPYRIGHT L’institut du thorax, S. Bellanger
This project is funded through the “Innovez” program of I-site NExT of Nantes University, supported by the French government as part of the Plan d’Investissement France 2030.
@l’institut du thorax @Inserm @Nantes Université @CNRS @CHU de Nantes @I-site NExT
